| Literature DB >> 20629726 |
Xue Jun Liu1, Michael W Salter.
Abstract
Glutamate is the major excitatory neurotransmitter in the central nervous system. Considerable evidence suggests that both ionotropic and metabotropic glutamate receptors are involved in pain hypersensitivity. However, glutamate receptor-based therapies are limited by side-effects because the activities of glutamate receptors are essential for many important physiological functions. Here, we review recent key findings in molecular and cellular mechanisms of glutamate receptor regulation and their roles in triggering and sustaining pain hypersensitivity. Targeting these molecular mechanisms could form the basis for new therapeutic strategies for the treatment of chronic pain.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20629726 PMCID: PMC3589563 DOI: 10.1111/j.1460-9568.2010.07351.x
Source DB: PubMed Journal: Eur J Neurosci ISSN: 0953-816X Impact factor: 3.386